Skip to content
10-Q

Quarterly Report

ZYNERBA PHARMACEUTICALS, INC.

0001558370-23-014705

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 9, 2023 53.94M sh
Shares Diluted Q2 2023 · Jun 30, 2023 50.15M sh
Shares Diluted Q2 2023 · Jun 30, 2023 49.3M sh
Shares Diluted Q2 2023 · Jun 30, 2022 41.41M sh
Shares Diluted Q2 2023 · Jun 30, 2022 40.86M sh
Capex Q2 2023 · Jun 30, 2023 $97.95K
Capex Q2 2023 · Jun 30, 2022 $51.61K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$16.3M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$7.68M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $35.97M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $50.64M
Stockholders Equity Q2 2023 · Jun 30, 2023 $29.02M
Stockholders Equity Q2 2023 · Mar 31, 2023 $38.97M
Stockholders Equity Q2 2023 · Dec 31, 2022 $46.23M
Stockholders Equity Q2 2023 · Jun 30, 2022 $57.24M
Stockholders Equity Q2 2023 · Mar 31, 2022 $65.17M
Stockholders Equity Q2 2023 · Dec 31, 2021 $70.91M
Current Liabilities Q2 2023 · Jun 30, 2023 $11.46M
Current Liabilities Q2 2023 · Dec 31, 2022 $9.17M
Total Liabilities Q2 2023 · Jun 30, 2023 $11.46M
Total Liabilities Q2 2023 · Dec 31, 2022 $9.29M
Current Assets Q2 2023 · Jun 30, 2023 $39.29M
Current Assets Q2 2023 · Dec 31, 2022 $54.78M
Total Assets Q2 2023 · Jun 30, 2023 $40.48M
Total Assets Q2 2023 · Dec 31, 2022 $55.52M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.21
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.42
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.24
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.45
Eps Basic Q2 2023 · Jun 30, 2023 −$0.21
Eps Basic Q2 2023 · Jun 30, 2023 −$0.42
Eps Basic Q2 2023 · Jun 30, 2022 −$0.24
Eps Basic Q2 2023 · Jun 30, 2022 −$0.45
Sga Expense Q2 2023 · Jun 30, 2023 $3.97M
Sga Expense Q2 2023 · Jun 30, 2023 $7.36M
Sga Expense Q2 2023 · Jun 30, 2022 $3.72M
Sga Expense Q2 2023 · Jun 30, 2022 $7.48M
Rd Expense Q2 2023 · Jun 30, 2023 $7.17M
Rd Expense Q2 2023 · Jun 30, 2023 $14.24M
Rd Expense Q2 2023 · Jun 30, 2022 $5.45M
Rd Expense Q2 2023 · Jun 30, 2022 $10.59M
Net Income Q2 2023 · Jun 30, 2023 −$10.78M
Net Income Q2 2023 · Jun 30, 2023 −$20.9M
Net Income Q2 2023 · Mar 31, 2023 −$10.11M
Net Income Q2 2023 · Jun 30, 2022 −$9.85M
Net Income Q2 2023 · Mar 31, 2022 −$8.49M
Operating Income Q2 2023 · Jun 30, 2023 −$11.14M
Operating Income Q2 2023 · Jun 30, 2023 −$21.61M
Operating Income Q2 2023 · Jun 30, 2022 −$9.17M
Operating Income Q2 2023 · Jun 30, 2022 −$18.07M